As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Samrat Pharmachem has confirmed that the activities in relation to both physical and electronic share transfer facility during the period April 1, 2022 to March 31, 2023 are maintained by the Company’s Registrar and Share Transfer Agent - Link Intime India a Category-I, Registrar & Share Transfer Agent (RTA), registered with the Securities and Exchange Board of India (SEBI) vide Registration Number: INR000004058.
The above information is a part of company’s filings submitted to BSE.
